Diana Maria Lopategui1,2, Evelyne Lerut3, Maarten Naesens4,5, Rita Van Damme-Lombaerts6, Elena Levtchenko6, Noël Knops6. 1. University of Barcelona, Barcelona, Spain. dlopategui@gmail.com. 2. Department of Pediatric Nephrology and Solid Organ Transplantation, University Hospitals Leuven, Leuven, Belgium. dlopategui@gmail.com. 3. Department of Morphology and Molecular Pathology, University Hospitals Leuven, Leuven, Belgium. 4. Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium. 5. Department of Nephrology, University Hospitals Leuven, Leuven, Belgium. 6. Department of Pediatric Nephrology and Solid Organ Transplantation, University Hospitals Leuven, Leuven, Belgium.
Abstract
BACKGROUND: Severe multilayering (ML) of the peritubular capillary basement membranes in kidney allografts is considered to be an ultrastructural hallmark of chronic antibody-mediated rejection (CAMR). We describe here the unexpected findings in a young male adolescent with underlying focal segmental glomerulosclerosis who underwent a living-related donor transplant procedure, a case which brought into question the specificity of ML. METHODS: The patient received a kidney from his mother, whose donor screening was unremarkable. He developed nephrotic-range proteinuria shortly after the procedure. Biopsies performed within the first 6 months after transplantation demonstrated ML (5-6 layers). RESULTS: Since there were no other criteria for CAMR, electron microscopic analysis of the baseline biopsy was performed, which in retrospect also demonstrated ML. The donor is still asymptomatic after 7 years of follow-up, with normal renal function and no proteinuria. CONCLUSIONS: We discuss the phenomenon of ML in renal disease and together with the findings in our case would like to draw attention to the fact that ML in the setting of renal transplantation is not specific to CAMR, as it can exist in several kidney diseases and even in asymptomatic donors.
BACKGROUND: Severe multilayering (ML) of the peritubular capillary basement membranes in kidney allografts is considered to be an ultrastructural hallmark of chronic antibody-mediated rejection (CAMR). We describe here the unexpected findings in a young male adolescent with underlying focal segmental glomerulosclerosis who underwent a living-related donor transplant procedure, a case which brought into question the specificity of ML. METHODS: The patient received a kidney from his mother, whose donor screening was unremarkable. He developed nephrotic-range proteinuria shortly after the procedure. Biopsies performed within the first 6 months after transplantation demonstrated ML (5-6 layers). RESULTS: Since there were no other criteria for CAMR, electron microscopic analysis of the baseline biopsy was performed, which in retrospect also demonstrated ML. The donor is still asymptomatic after 7 years of follow-up, with normal renal function and no proteinuria. CONCLUSIONS: We discuss the phenomenon of ML in renal disease and together with the findings in our case would like to draw attention to the fact that ML in the setting of renal transplantation is not specific to CAMR, as it can exist in several kidney diseases and even in asymptomatic donors.
Authors: K Morozumi; T Oikawa; M Fukuda; K Sugito; O Takeuchi; A Oda; T Fujinami; A Takeda; K Uchida Journal: Transplant Proc Date: 1996-02 Impact factor: 1.066
Authors: C B Drachenberg; E Steinberger; E Hoehn-Saric; A Heffes; D K Klassen; S T Bartlett; J C Papadimitriou Journal: Ultrastruct Pathol Date: 1997 May-Jun Impact factor: 1.094
Authors: George Liapis; Harsharan K Singh; Vimal K Derebail; Adil M H Gasim; Tomasz Kozlowski; Volker Nickeleit Journal: Transplantation Date: 2012-09-27 Impact factor: 4.939
Authors: G Einecke; B Sis; J Reeve; M Mengel; P M Campbell; L G Hidalgo; B Kaplan; P F Halloran Journal: Am J Transplant Date: 2009-11 Impact factor: 8.086
Authors: Heinz Regele; Georg A Böhmig; Antje Habicht; Daniela Gollowitzer; Martin Schillinger; Susanne Rockenschaub; Bruno Watschinger; Dontscho Kerjaschki; Markus Exner Journal: J Am Soc Nephrol Date: 2002-09 Impact factor: 10.121
Authors: M Haas; B Sis; L C Racusen; K Solez; D Glotz; R B Colvin; M C R Castro; D S R David; E David-Neto; S M Bagnasco; L C Cendales; L D Cornell; A J Demetris; C B Drachenberg; C F Farver; A B Farris; I W Gibson; E Kraus; H Liapis; A Loupy; V Nickeleit; P Randhawa; E R Rodriguez; D Rush; R N Smith; C D Tan; W D Wallace; M Mengel Journal: Am J Transplant Date: 2014-02 Impact factor: 8.086